Skip to main content

Table 1 Comparison of the baseline demographics of elderly and younger pancreatic cancer patients (n = 895)

From: Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients

 

Total (n = 895)

Elderly group (n = 659)

Younger group (n = 236)

P-value

Age (y)

71.9 ± 11.1

77.2 ± 6.9

57.2 ± 6.1

NA

Sex (Female)

435 (48.6%)

354 (53.7%)

81 (34.3%)

<.0001

Tumor location, including the pancreatic head

506 (56.5%)

376 (57.1%)

130 (55.1%)

0.51

Stage

I

15 (1.7%)

13 (2.0%)

2 (0.8%)

0.25

II

18 (2.0%)

16 (2.4%)

2 (0.8%)

0.14

III

57 (6.4%)

39 (5.9%)

18 (7.7%)

0.36

IVa

232 (25.9%)

172 (26.1%)

60 (25.4%)

0.84

IVb

573 (64.0%)

419 (63.6%)

154 (65.3%)

0.65

Treatment

CT

519 (58.0%)

344 (43.4%)

175 (60.3%)

<.0001

BSC

376 (42.0%)

315 (39.8%)

61 (21.0%)

<.0001

Death resulting from PC

584 (96.1%)

419 (95.2%)

165 (98.2%)

0.09

  1. Elderly group: patients aged ≥65 years; Younger group: patients aged <65 years
  2. Abbreviations: CT chemotherapy, BSC best supportive care, PC pancreatic cancer, NA not applicable